Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
Condition: Type 1 Diabetes Interventions: Drug: Empagliflozin; Drug: Placebo Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre; Diabetes Canada Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Canada Health | Diabetes | Diabetes Type 1 | Empagliflozin | Endocrinology | Insulin | Jardiance | Research